Melanie Dumas Selected Research

1-bromo-2,5-bis(4-hydroxystyryl)benzene

3/2014

K114 inhibits A-beta aggregation and inflammation in vitro and in vivo in AD/Tg mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Melanie Dumas Research Topics

Disease

5	Cardiotoxicity 01/2020 - 01/2017
3	Amyloid Plaque 03/2014 - 01/2013
1	Hypertension (High Blood Pressure) 01/2020
1	Edema (Dropsy) 01/2020
1	Growth Disorders 01/2020
1	Poisoning 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2018
1	Hyperplasia 06/2013
1	Alzheimer Disease (Alzheimer's Disease) 06/2013

Drug/Important Bio-Agent (IBA)

4	Ketamine FDA LinkGeneric 01/2019 - 01/2017
3	Acetylcarnitine (Alcar)IBA 01/2020 - 01/2017
2	Verapamil (Calan)FDA LinkGeneric 01/2020 - 01/2017
1	1,4-dihydropyridine (dihydropyridine)IBA 01/2020
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2020
1	Nifedipine (Adalat)FDA LinkGeneric 01/2020
1	Adenosine Triphosphate (ATP)IBA 09/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	Anesthetics (Anesthetic Agents)IBA 01/2018
1	8- (N,N- diethylamino)octyl- 3,4,5- trimethoxybenzoateIBA 01/2017
1	LigandsIBA 03/2014
1	1-bromo-2,5-bis(4-hydroxystyryl)benzeneIBA 03/2014
1	Peptides (Polypeptides)IBA 03/2014
1	VaccinesIBA 06/2013
1	Clioquinol (Vioform)FDA Link 06/2013
1	Lysergic Acid Diethylamide (LSD)IBA 06/2013
1	Retinaldehyde (Retinal)IBA 06/2013
1	Congo RedIBA 01/2013
1	Black-GoldIBA 01/2013